Detalles de la búsqueda
1.
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer.
Prostate
; 83(3): 227-236, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36382533
2.
A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer.
Clin Genitourin Cancer
; 22(2): 558-568.e3, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38342659
3.
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes.
Cancer Discov
; 13(3): 632-653, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36399432
4.
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer.
JCO Precis Oncol
; 6: e2200329, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36103646
5.
Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis.
Clin Cancer Res
; 28(5): 928-938, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34907080
6.
The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response.
Cancer Res
; 82(16): 2848-2859, 2022 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35731919
Resultados
1 -
6
de 6
1
Próxima >
>>